ArticleTheranostics2020

Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: A quantitative dose-escalation study.

Floris Jan Voskuil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.